PMV Pharmaceuticals, Inc. (PMVP)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. David H. Mack Ph.D. | Co-Founder, CEO, President & Director | 943.07k | -- | 1962 |
| Dr. Arnold J. Levine Ph.D. | Co-Founder, Independent Director & Member of Scientific Advisory Board | 140k | -- | 1940 |
| Mr. Michael Carulli | Chief Financial Officer | 532.8k | -- | 1974 |
| Dr. Deepika Jalota Pharm.D. | Chief Development Officer | 638.36k | -- | 1977 |
| Mr. Robert Ticktin J.D. | General Counsel, COO & Company Secretary | -- | -- | 1962 |
| Mr. Tim Smith | Senior VP and Head of Corporate Development & Investor Relations | -- | -- | -- |
| Ms. Crystal Zuckerman | Vice President of Human Resources | -- | -- | -- |
| Dr. Binh Vu Ph.D. | Senior Vice President of Drug Discovery & CMC | -- | -- | -- |
| Dr. Marc Fellous M.D. | Senior VP and Head of Clinical Development & Medical Affairs | -- | -- | -- |
| Ms. Laura De Leon | VP & Head of Clinical Operations | -- | -- | -- |
PMV Pharmaceuticals, Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 47
Description
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. It's lead product candidate is rezatapopt, an orally available small molecule that potently and selectively correct p53 misfolding caused by p53 mutation, Y220C, while sparing wild-type p53. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is based in Princeton, New Jersey.
Corporate Governance
Upcoming Events
August 6, 2025 at 12:30 PM UTC - August 11, 2025 at 12:30 PM UTC
PMV Pharmaceuticals, Inc. Earnings Date
Recent Events
November 25, 2024 at 12:00 AM UTC
CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission